Cathinones are a class of stimulant drugs that share a common chemical backbone with amphetamine. The original compound, cathinone, occurs naturally in the khat plant (Catha edulis), a shrub native to Ethiopia and Yemen that people have chewed for centuries for its energizing effects. In recent decades, chemists have created dozens of synthetic versions, often sold under street names like “bath salts,” that can be far more potent and unpredictable than the natural compound.
The Khat Plant and Natural Cathinone
Cathinone is the primary psychoactive alkaloid in khat, a plant belonging to a large botanical family with hundreds of species. Fresh khat leaves contain the highest concentration of cathinone, which breaks down relatively quickly after the leaves are picked. This is why khat is traditionally chewed fresh. As the leaves dry, cathinone converts into cathine, a milder stimulant with weaker effects.
Chemically, cathinone is almost identical to amphetamine. The only structural difference is a single oxygen atom attached to the carbon chain, making it what chemists call a “beta-keto analogue” of amphetamine. This small change preserves the stimulant properties but makes the effects somewhat less potent than amphetamine itself. That oxygen atom, however, also serves as a convenient anchor point for chemical modifications, which is how the synthetic cathinone market exploded.
How Cathinones Affect the Brain
Cathinones work by flooding the brain with three chemical messengers: dopamine (linked to pleasure and reward), norepinephrine (linked to alertness and the fight-or-flight response), and serotonin (linked to mood and emotional regulation). They accomplish this by hijacking the transporter proteins that normally recycle these chemicals back into nerve cells.
Most cathinones act as “releasers,” meaning they don’t just block recycling but actually reverse the process, forcing stored neurotransmitters out of nerve cells and into the spaces between them. This creates a rapid surge of stimulation. The ratio of dopamine to serotonin release varies dramatically depending on the specific cathinone, and this ratio largely determines whether a particular compound feels more like amphetamine (dopamine-heavy, producing euphoria and energy) or more like ecstasy (serotonin-heavy, producing empathy and emotional warmth).
Natural cathinone is heavily tilted toward dopamine release. In lab studies, it releases dopamine at concentrations roughly 50 times lower than what’s needed to release serotonin, making it a potent and selective stimulant. Different synthetic modifications shift this balance. Adding certain chemical groups to the molecule can dramatically increase serotonin activity, while others enhance dopamine release even further.
Common Synthetic Cathinones
The synthetic cathinones that have drawn the most public attention include:
- Mephedrone (4-methylmethcathinone): One of the most widely used synthetic cathinones, with effects users describe as a mix between cocaine and ecstasy. It releases both dopamine and serotonin.
- MDPV (3,4-methylenedioxypyrovalerone): A particularly potent compound that blocks dopamine recycling rather than forcing release. This makes its effects intense and long-lasting, and it carries a high risk of compulsive redosing.
- Methylone: Structurally similar to MDMA (ecstasy), with more balanced serotonin and dopamine effects.
- Methcathinone: The simplest modification of natural cathinone, adding a single methyl group. It is 86 times more selective for dopamine release over serotonin, making it a powerful, almost purely stimulant drug.
The term “bath salts” became infamous around 2010-2012 and typically referred to products containing mephedrone, MDPV, or both. These were sold in gas stations and head shops, labeled “not for human consumption” to skirt drug laws. The name had nothing to do with actual bathing products.
Physical Effects and Cardiovascular Risks
Synthetic cathinones push the cardiovascular system hard. In a review of 222 poisoning cases involving heart-related complications, 62% involved a resting heart rate above 100 beats per minute, 31% had high blood pressure, and 26% reported palpitations. Some cases progressed to serious events including dangerously high blood pressure (systolic readings above 180 mmHg), abnormal heart rhythms, and cardiac arrest.
Beyond the heart, common physical effects include elevated body temperature (hyperthermia), excessive sweating, insomnia, and teeth grinding. Different synthetic cathinones produce slightly different patterns. Users of 3-MMC, for instance, most commonly experience rapid heart rate and agitation, while mephedrone users more frequently report sweating, headache, palpitations, and nausea.
The long-term cardiovascular effects of synthetic cathinones haven’t been thoroughly studied, but researchers suspect they may mirror what’s seen with chronic khat use: sustained high blood pressure, spasm of the coronary arteries, heart attack, stroke, and heart failure.
Psychological Effects and Risks
At lower doses, cathinones produce the effects users are seeking: euphoria, increased energy, heightened sociability, and a sense of confidence. These effects come on fast. In animal studies, natural cathinone produces noticeable effects within five minutes, faster than both amphetamine (15-30 minutes) and cocaine. The tradeoff is a shorter duration of action, often around 60 minutes for the natural compound, which can drive users to redose frequently.
At higher doses or with repeated use, the psychological profile gets much darker. Paranoia, hallucinations, severe agitation, confusion, and delusions can emerge. In serious cases, this escalates into a condition sometimes called “excited delirium,” a combination of paranoia, extreme agitation, and violent behavior that poses serious risks to both the user and people around them. This syndrome has been repeatedly documented in emergency departments following synthetic cathinone binges.
One Cathinone Is a Prescription Medication
Not all cathinones are illicit. Bupropion, widely prescribed for depression, smoking cessation, and weight management, is technically a substituted cathinone. It’s the only cathinone approved for medical use. Bupropion’s chemical modifications make it act primarily as a mild reuptake inhibitor of dopamine and norepinephrine rather than a releaser, which gives it therapeutic effects without the intense euphoria or abuse potential of its chemical relatives.
Legal Status in the United States
Most well-known synthetic cathinones are Schedule I controlled substances under the Controlled Substances Act, meaning they’re classified as having high abuse potential and no accepted medical use. The DEA has placed numerous compounds in this category, including mephedrone, MDPV, methylone, and alpha-PVP (sometimes called “flakka”).
The challenge for regulators is that underground chemists continuously tweak the cathinone structure to create technically novel compounds that fall outside existing schedules. The DEA has responded by adding new compounds over time. As recently as late 2024, it proposed scheduling 4-chloromethcathinone (4-CMC), noting its similarity to previously scheduled synthetic cathinones and to amphetamine and methamphetamine. This cat-and-mouse dynamic means new, unscheduled cathinones regularly appear on the market with unknown safety profiles, making them especially risky for users who may not know exactly what they’re taking or how potent it is.